Media & Technology
Healthier Choices Management Corp. (OTCMKTS: HCMC) Rise of the Mighty, PMI Patent Infringement Lawsuit & Rights Offering
Healthier Choices Management Corp. (OTCMKTS: HCMC) continues to move steadily higher with power in recent days since popping north off the $0.0012 where it had been stuck for some time. Microcapdaily called it perfectly with our article on the 15th suggesting a powerful comeback was brewing. HCMC has emerged in recent months as an investors favorite and is currently among the most actively searched and talked about stocks in small caps with well over 400,000 shareholders of record. Currently under heavy accumulation HCMC is moving steadily northbound with many new investors buying in every day. On wednesday the stock traded $4.5 million in dollar volume on 2.3 billion shares traded. HCMC is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over $0.0065 and its blue skies ahead.
Just last week HCMC announced announced a rights offering that if fully subscribed will raise up to $100,000,000 in gross proceeds for the Company. The net proceeds will be used for general working capital purposes, including the protection of the Company’s intellectual property rights through litigation and other methods as well as other initiatives. The big story is HCMC patent infringement lawsuit against billion-dollar conglomerate Philip Morris USA, Inc. and Philip Morris Products S.A. A settlement or licensing deal could drive HCMC into a whole new stratosphere with no limit to how high HCMC could go. The patent infringement lawsuit against Philip Morris USA, Inc. is moving forward and gaining steam. Representing HCMC is Cozen O’Connor ranked among the top 100 law firms in the country and employing more than 775 attorneys in 29 cities across two continents. The firm’s diverse client list includes global Fortune 500 companies, middle-market firms poised for growth, high-profile individuals and HCMC who must have a seriously solid case against PMI with outstanding chances. HCMC is already a revenue powerhouse doing over $1 million per month in sales in 2020; on March 5 HCMC announced financial results for the fourth quarter and fiscal year ended December 31, 2020. In Q4 the Company delivered improvement in adjusted EBITDA for fiscal year 2020. Net sales from continued operations for the year ended December 31, 2020 amounted to $13.9 million, compared to $15.1 million during the same period last year.
Healthier Choices Management Corp. (OTCMKTS: HCMC) is focused on providing its customers with a healthier alternatives to everyday lifestyle choices. The Company operates through its various subsidiaries including Healthy Choice Markets and Healthy Choice Markets 2. HCMC also owns Ada’s Natural Market, a 18,000 sq. ft. full-service grocery store serving the Fort Myers, FL, and three Paradise Health & Nutrition locations in the greater Melbourne, Florida area. The Company also operates 8 vape stores across the southeast United States offering smokers an alternative to traditional cigarettes. HCMC vape stores brands include The Vape Store, Vapor Max, Vulcan Vape, and The Grab Bag locations. HCMC Vape Stores provide an endless selection of industry best vaping hardware and e-liquids, giving its consumers a way to get their nicotine without the smoke, tar, ash or carbon monoxide found in traditional cigarettes. The Company is led by CEO Jeffrey Holman; a seasoned executive and corporate lawyer who also serves as President of Jeffrey E. Holman & Associates, P.A., a South Florida Based law firm. John Ollet the CFO previously served as Executive Vice President-Finance for Systemax, Inc. (NYSE:SYX) North America Technology Division for 10 years. SYX currently trades at $43 per share on the NYSE and does over a billion dollars in annual revenues.
HCMC owns a valuable patent portfolio related to both vape technology and also manufacturing processes and procedures for an imitation nicotine product. HCMC’s patented Q-Cup™ technology is based on a small, quartz cup called the Q-Cup™, which a customer can purchase already filled by a third party in some regions, or can partially fill themselves with either cannabis or CBD concentrate (approximately 50mg), also purchased from a third party. The Q-Cup™ can then be inserted into the patented Q-Unit™, which heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ and Q-Unit™ technology provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. The Q-Cup™ can also be used in other devices as a convenient micro-dosing system. Most recently, the company formed a wholly owned subsidiary, HCMC Intellectual Property Holdings, LLC, to hold and market its intellectual property assets. This subsidiary will own all of the patents, trademarks and other intellectual property of HCMC and will be utilized in the company’s attempt to monetize its intellectual property.
The Company is already a revenue powerhouse doing over $1 million per month in sales in 2020; on March 5 HCMC announced financial results for the fourth quarter and fiscal year ended December 31, 2020. In Q4 the Company delivered improvement in adjusted EBITDA for fiscal year 2020. Net sales from continued operations for the year ended December 31, 2020 amounted to $13.9 million, compared to $15.1 million during the same period last year.
In its patent infringement lawsuit against Philip Morris, Cozen O’Connor is representing HCMC; Cozen O’Connor is ranked among the top 100 law firms in the country and employs more than 775 attorneys in 29 cities across two continents. Cozen O’Connor is a full-service firm with nationally recognized practices in litigation, business law, and government relations, and its attorneys have experience operating in all sectors of the economy. The firm’s diverse client list includes global Fortune 500 companies, middle-market firms poised for growth, high-profile individuals and ambitious upstarts like HCMC. Cozen O’Connor has been awarded as the #1 law firm of the year several times, amongst dozens of other awards and would not take on a giant such as Philip Morris unless they knew for sure they have a very strong case and excellent chances.
(1) HCMC’s Opposition to PM’s MTD (March 11, 2021): Absent an extension of time to respond, HCMC’s opposition to PM’s MTD is due on or before March 11, 2021. I would expect some form of opposition that includes arguments that (a) dismissal is not warranted because discovery has not happened yet and discovery is needed in order to determine whether combustion is a process that occurs in the accused devices, (b) dismissal is not warranted without a claim construction that construes, amongst other terms, the term “combustion”, and (c) testimony, by way of a declaration, explaining that it is not dispositive, based on the documentary evidence presented by PM’s MTD, that there is no combustion. A well written opposition brief hitting those points will likely result in denial of the MTD. I would also expect that there be a request by HCMC to correct any defects in their complaint, should the court deem there to be any defects. That request is granted liberally and would overcome the MTD for the time being.
(2) Rule 26(f) Meet and Confer (March 15, 2021): This is held in private between lead counsel for all parties. The parties are required to confer in person in an effort to settle the case, discuss discovery, limit issues, and discuss other matters.
(3) PM’s Reply to HCMC’s Opposition (March 25, 2021): Absent an extension of time, PM will have the opportunity to reply to HCMC’s opposition brief regarding the MTD.
(4) Joint Preliminary Report and Discovery Plan (April 12, 2021). Absent an extension of time, the parties will file this report and plan that results from the parties’ Rule 26(f) meeting and conference and sets forth numerous details including, amongst other things, the progress of settlement discussions, a proposed schedule of the case for fact discovery, motion practice, expert discovery, and trial.
(5) Infringement Contentions (May 12, 2021): HCMC is due to serve contentions showing infringement where HCMC will identify (these are usually exchanged between the parties and not made public or filed publicly with sensitive information redacted): (a) Each claim of each patent in suit that is allegedly infringed by each opposing party; (b) Separately for each asserted claim, each accused apparatus, method, composition or other instrumentality (“Accused Instrumentality”) of each accused party of which the claiming party is aware.
https://twitter.com/stockshotr/status/1385744645112705028
https://twitter.com/audreydankelma1/status/1386441181333127173
To Find out the inside Scoop on HCMC Subscribe to Microcapdaily Right Now by entering your Email in the box below
On April 20, HCHC announced it filed a registration statement on Form S-1 with the sec for a Rights Offering to its stockholders. Jeffrey Holman, the CEO of HCMC, released the following letter to HCMC’s stockholders in connection with the Rights Offering:
Dear Valued Shareholders,
First and foremost, on behalf of the Board of Directors, our Executive staff, and everyone at Healthier Choices Management Corp. I would like to take this opportunity to thank our valued shareholders for their support through the years, and also to welcome all of our more recent shareholders. Worth mentioning is that our shareholder count is now at an all-time high, and presently sits at over 400,000 shareholders strong.
Additionally, I would like to publicly thank HCMC’s 124 employees who have risen to the occasion during the past year despite the unprecedented challenges associated with the pandemic.
Before I discuss the present Rights Offering to our shareholders, I would like to state clearly that this Rights Offering should not be confused with a reverse stock split. The Company is not pursuing a reverse stock split concurrently, or in conjunction with this Rights Offering. Please also note that in general, if the Company’s board of directors at some time in the future deemed it in the best interests of the Company and its shareholders to recommend a reverse split, it would have to send out a proxy to the common shareholders detailing its reasons. It would then need to be approved by shareholders owning over 50% of the common stock of the Company. Without this majority shareholder approval, no reverse stock split can occur.
Now onward to the Rights Offering. In order to finance the expansion and protection of our intellectual property and the Company’s various growth initiatives, HCMC will require additional funding. In an effort to achieve this funding in a potentially non-dilutive manner to current shareholders, our board has decided to move forward with a Rights Offering exclusively for our shareholders. This Rights Offering essentially allows our shareholders the ability to purchase our common stock directly from the Company at a discounted price. We hope to achieve our goal of raising capital and building a significant war chest, while offering you the right to participate, and not face the dilution that typically happens when a public company receives an investment from an investment fund or institutional investors. The Company has retained Maxim Group LLC to act as its exclusive financial advisor and dealer-manager for this Rights Offering. Broadridge is being retained to act as the subscription agent.
The purpose of this Rights Offering is to raise equity capital in a cost-effective and potentially non-dilutive manner that provides all of our existing shareholders the opportunity to participate, purchase, and own up to approximately an additional 25% of the Company’s common stock. If fully subscribed, the Company will raise up to $100,000,000 in gross proceeds. The net proceeds will be used for general working capital purposes, including the protection of our intellectual property rights through litigation and other methods, funding future research and development for both our intellectual property suite and product offerings, and funding growth initiatives and expansion for our health food, vitamin and supplements, and vape segments, both online and in brick and mortar stores. The Company’s board believes that in order to move forward with the Company’s above initiatives, and efforts to attain its goal of raising shareholder value, the Company requires additional capital and that this Rights Offering is the most favorable way to our shareholders to achieve these goals. Again, for purposes of clarity, this is not a reverse split, and management is not asking you to vote on a reverse split as part of, or concurrently with this offering.
Although the full details of the Rights Offering have been included in a prospectus filed this morning with the SEC, I will attempt here to break down some of the most important bullet points associated with this Rights Offering. This is meant only as an overview and you need to read the entire prospectus before making any investment in HCMC.
For every 4 shares of common stock that you own, you will be entitled to purchase 1 share of common stock directly from the Company at a discounted price. This right is referenced to as a “basic right.” The purchase price will be a 25% discount to the volume-weighted average (VWAP) of the sales prices of our shares of common stock on the OTC Pink Sheets for the five consecutive trading days ending on the expiration date of the offering. This price is called the “Actual Subscription Price.” So, by way of example, if the VWAP as described above is $0.0016, your discounted Actual Subscription Price would be $0.0012 per share.
After the Company has completed the process with the SEC, you will be given an estimated Subscription Price, which you will use when sending in your request for discounted shares. For example, if the estimated Subscription Price is $0.0012 and you wish to purchase 1,000,000 shares, you will send payment in the amount of $1,200.
However, the total amount of shares that you will actually receive will be based upon the Actual Subscription Price once it is finalized at the expiration of the offering. So, using the example above, if you submit $1,200 based on the Estimated Subscription Price of $0.0012 and the Actual Subscription Price drops to $0.0010, you will receive 1,200,000 shares. If the Actual Subscription Price increases to $0.0014, you will receive 857,143 shares. However, in both cases you will be receiving a 25% discount to the VWAP as described above.
You may attempt to oversubscribe, or buy more than your basic right under the Rights Offering, and your request will be filled on a pro-rata basis from any shares that were not purchased by other shareholders. If you request to oversubscribe and you are not able to purchase the full amount, you will receive a refund for the amount of oversubscribed shares not sold to you. If you fully exercise your entitled allotment of shares, you will not be diluted as a result of the Rights Offering. If you oversubscribe and purchase these additional shares, you will actually increase your percentage of ownership in the Company. If you decide not to subscribe at all, your amount of shares will NOT be reduced, but you will own less of the Company on a percentage basis and this will result in dilution. Your right to purchase under this Rights Offering cannot be assigned or traded, has no value, and terminates if not used by the expiration of the Rights Offering. For the full release go here.
https://twitter.com/DahoMillion/status/1384684046681260036
For More on HCMC Subscribe Right Now
Healthier Choices Management Corp. (OTCMKTS: HCMC) continues to move steadily higher with power in recent days since popping north off the $0.0012 where it had been stuck for some time. Microcapdaily called it perfectly with our article on the 15th suggesting a powerful comeback was brewing. HCMC has emerged in recent months as an investors favorite and is currently among the most actively searched and talked about stocks in small caps with well over 400,000 shareholders of record. Currently under heavy accumulation HCMC is moving steadily northbound with many new investors buying in every day. On wednesday the stock traded $4.5 million in dollar volume on 2.3 billion shares traded. HCMC is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over $0.0065 and its blue skies ahead. Just last week HCMC announced announced a rights offering that if fully subscribed will raise up to $100,000,000 in gross proceeds for the Company. The net proceeds will be used for general working capital purposes, including the protection of the Company’s intellectual property rights through litigation and other methods as well as other initiatives. The big story is HCMC patent infringement lawsuit against billion-dollar conglomerate Philip Morris USA, Inc. and Philip Morris Products S.A. A settlement or licensing deal could drive HCMC into a whole new stratosphere with no limit to how high HCMC could go. The patent infringement lawsuit against Philip Morris USA, Inc. is moving forward and gaining steam. Representing HCMC is Cozen O’Connor ranked among the top 100 law firms in the country and employing more than 775 attorneys in 29 cities across two continents. The firm’s diverse client list includes global Fortune 500 companies, middle-market firms poised for growth, high-profile individuals and HCMC who must have a seriously solid case against PMI with outstanding chances. HCMC is already a revenue powerhouse doing over $1 million per month in sales in 2020; on March 5 HCMC announced financial results for the fourth quarter and fiscal year ended December 31, 2020. In Q4 the Company delivered improvement in adjusted EBITDA for fiscal year 2020. Net sales from continued operations for the year ended December 31, 2020 amounted to $13.9 million, compared to $15.1 million during the same period last year. . Microcapdaily first reported on HCMC on January 27 as the stock was moving up in the triple zeroes. We will be updating on HCMC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with HCMC.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in HCMC either long or short and we have not been compensated for this article.
Meta Materials (NASDAQ: MMAT) witnessed a significant uptick in trading activity on January 16th, 2024, resulting in a notable 20% increase in its stock value by market close. Intrigued by this surge, we explored various sources, including press releases, SEC filings, and social media, to identify the catalyst behind this sudden gain.
Unexpectedly our research revealed no recent material releases. Instead, the surge seems tied to an announcement from a few days ago that didn’t grab much attention at first. As time passed, it started generating more buzz but there’s still a lot more to dig into and a number of ideas to consider for today’s rally.
If you haven’t caught up on our previous analyses of MMAT, you can find the overview here. In this report, we aim to explore the cause-and-effect dynamics of recent events, offering insights that might illuminate expectations for Meta Materials in the near future.
Background:
If you’re new to MMAT or haven’t been a long-time follower, let’s kick things off with a quick intro to the company.
Meta Materials stands at the forefront of advanced materials and nanotechnology. Their focus is on pioneering novel products and technologies utilizing sustainable and innovative scientific approaches. The interesting part is their advanced materials have the transformative power to enhance a variety of common products, infusing them with heightened intelligence and sustainability.
Leveraging its technology platforms, they’re capable of empowering global brands in creating cutting-edge products that elevate overall performance.
Their technology has application across multiple industries including aerospace and defense, consumer electronics, 5G communications, batteries, authentication, automotive, and clean energy. Their agreement with Panasonic is certainly a great start to empowering their growth in one of many verticals. Overall the TAM is ~$32B and with current growth rates, it’ll increase to a whopping ~$61B by 2026.
MMAT’s goal is to shape a smarter and more sustainable world. If you look through their presentation, you can continue to evaluate the many ways their technology transforms everyday lives. We highly suggest you take a look.
Additional Resources:
- @LauraLoomer’s video on MMAT
- @metaheadj’s post on X, displaying Rob Stone‘s response update for an investor
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
What Happened:
So, MMAT issued a press release on January 11th, 2024, announcing a proposed settlement with the Securities and Exchange Commission (SEC) concerning an investigation related to the Torchlight Energy Resources, Inc. and Metamaterial Inc. merger.
According to the release, The company has extended a settlement offer (Proposed SEC Settlement) to the SEC’s Division of Enforcement. This proposed settlement aims to address concerns regarding antifraud, reporting, books and records, and internal accounting control provisions of securities laws. It is important to note that the Proposed SEC Settlement is contingent on approval by the SEC Commissioners, and the company cannot predict the approval timeline.
If accepted, the Proposed SEC Settlement would involve the SEC entering a cease-and-desist order and the company paying a civil money penalty of $1 million over a one-year period in four installments. Notably, the company would neither admit nor deny the findings outlined in the Order.
The company’s board of directors and management team view the Proposed SEC Settlement as beneficial for shareholders. If approved, it is expected to remove uncertainty surrounding the investigation, enabling the company to focus on advancing its business objectives.
So What:
If you’ve just read through the announcement and are confused, you’re not alone. It appears that many investors may have mis-read the press release, thinking that the SEC was being punished and MMAT was reaching a settlement agreement, but it appears to be the other way around.
In the event of approval, the company is obligated to pay a civil money penalty of $1 million. This penalty would be paid in four installments over the course of one year, following an agreed-upon payment plan. However, the PR also notes that the company cannot predict with certainty whether or when the Proposed SEC Settlement will even be approved by the SEC Commissioners.
According to another user on X, @AShortSqueeze, MMAT’s initial analysis has potentially revealed the motherload of counterfeit shares.
But if you scroll through the comments, you’ll see other users pointing out that this information is actually old news. This is just one of many widely circulated posts that might have been misunderstood.
Significant Coverage:
Another theory suggests that a notable influencer in the financial space, @MoonMarket_, has set their sights on the company and is conducting additional due diligence. With a substantial following of almost 75K users, the influencer’s involvement could have contributed to a significant fluctuation in today’s trading session. It’s important to recognize that X is packed with plenty of financial influencers, and blindly following their moves can be risky. Many are involved in day trades, momentum trading, or at least contemplating such strategies.
Conclusion:
The buzz around MMAT today seems fuelled by a mix of misrepresented themes and recycled news, creating the illusion of fresh, imminent developments.
As per usual, the magnitude of MMAT’s technology and potential integrations across various verticals continues to create a roar of excitement. On another front, we’re also continuing to see speculation about a short squeeze due to substantial amounts of counterfeit shares.
For now, patience is key and we suggest closely monitoring developments. MMAT especially tends to be quite volatile.
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by StartupStockPhotos from Pixabay
Meta Materials (NASDAQ: MMAT) has been a hot topic as of late, with investors all over the web talking about a potential resurgence. If we rewind to late 2020 and glance at their stock chart, we witness an impressive surge from ~$0.54 to a peak of $13.52, an astonishing 2400% gain within’ the span of a few months. If you’ve been following our articles lately, you’ll notice a similar kind of performance from Tempest Therapeutics’ (NASDAQ: TPST). This is of course a rare event, but there’s a noteworthy angle to consider. While TPST’s initial data release triggered a significant surge, what propelled it further appears to be its “Poison pill” strategy. Recent tweets from MMAT’s CEO suggest a similar strategy is in the works. Could MMAT experience a colossal gain reminiscent of 2021 or even rival TPST’s performance? Let’s delve into Meta Materials, its recent developments, and potential prospects to uncover what’s in store.
Background:
Meta Materials stands at the forefront of advanced materials and nanotechnology. Their focus is on pioneering novel products and technologies utilizing sustainable and innovative scientific approaches. The interesting part is their advanced materials have the transformative power to enhance common products, infusing them with heightened intelligence and sustainability. Leveraging its technology platforms, they’re capable of empowering global brands in creating cutting-edge products that elevate overall performance. Their technology has application across multiple industries including aerospace and defense, consumer electronics, 5G communications, batteries, authentication, automotive, and clean energy. Overall, that’s ~$32B TAM and with current growth rates, it’ll increase to a whopping ~$61B TAM by 2026. Their goal is to shape a smarter and more sustainable world. If you look through their presentation, there are a number of ways their technology can transform our everyday lives. We highly suggest you take a look.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Lawsuits:
You’ll notice MMAT has faced a challenging year as its valuation took a hit following the initiation of two separate class action lawsuits that stemmed from a short-seller report and statements related to Meta’s business combination with Torchlight Energy Resources.
We’ll keep this section short and focus on the accusations related to the business combination. If you’d like more information on the short seller lawsuit, click here.
Long story short, a shareholder filed a class action lawsuit against Meta on behalf of individuals who acquired the company’s publicly traded securities between September 20, 2020, and December 14, 2021. The lawsuit alleged violations of the Securities Exchange Act of 1934. The complaint outlined that Meta Materials, initially known as Torchlight Energy Resources, Inc., exaggerated its business connections, product capabilities, and pricing during its merger with Metamaterial Inc. The filing highlighted a subsequent SEC subpoena, leading to a share price drop. Additionally, a critical report by Kerrisdale Capital triggered another significant share price decline, further impacting investors.
However 11 days ago on October 2nd, 2023, there were significant positive developments regarding this situation. It appears that MMAT will no longer have this legal burden to bear. The lawsuits were entirely dropped, and the court ruled to dismiss all the allegations made against them. As you might of noticed, the initial announcement earlier this year led to a huge selloff. At the current moment, it’s trading at extremely low levels and many online believe there’s substantial upside.
Poison Pill:
As we previously mentioned, it appears the CEO, George Palikaras is working on a poison pill of his own. After Tempest Therapeutics (NASDAQ: TPST) released their latest data it brought ~2400% gain, but their poison pill managed to push that gain even further to ~4000%. If you’re not familiar with what a poison pill is, allow us to explain below.
A poison pill is a defensive strategy used by a company’s management to deter or prevent hostile takeovers or acquisitions by another entity. The term “poison pill” implies that it is intended to be unattractive or undesirable for the acquiring entity.
Typically, a poison pill involves issuing new shares or other financial instruments to existing shareholders, or allowing them to purchase shares at a significant discount, in the event that an outside entity acquires a certain percentage of the company’s shares. This dilutes the ownership and voting power of the acquiring entity, making the takeover more difficult or costly.
The objective is to make the acquisition financially less appealing or more difficult, encouraging potential acquirers to negotiate with the company’s board of directors instead of pursuing a hostile takeover.
Palikara just recently tweeted, “Revenue, strategic partnerships, cost efficiencies, hiring & paying for performance, non-dilutive capital, poison pill, relentless work, Revenue… Plenty of time 2 get in compliance, but our bar is set a lot higher than that.”
If you look through some of MMAT’s latest releases, you’ll notice they’ve announced various forms of funding, more recently they closed a financing for 50M with Lincoln Park Capital Fund, LLC.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Potential Application & Outlook:
Pay special attention to this section, as we’ll be spotlighting potential applications of MMAT’s technology and where they’re at in the commercialization process. Many believe the application alone could hold substantial returns for long-term shareholders.
One user from Twitter, @Seashellpants, has shared a video that outlines in great detail MMAT’s agreement with the Simon Fraser university, one of the top universities in Canada and worldwide.
In this video, we’ll catch a glimpse of how the R&D process is going so far and potential application across various verticals. You’ll need to be cautious, as this video may cause “Heavy breathing”.
We’ll provide a brief summary below, but don’t miss out on the hyperlink above. It’s not only entertaining, but also packed with valuable insights.
Breakdown of the Video:
Just over 2 years ago on October 5th, 2021 MMAT acquired Nanotech Security Corp. which is now considered a subsidiary of MMAT. If we delve into MMAT’s 10Q from May 12th, 2023, there are multiple updates on how their research is going with the Simon Fraser University. Within this 10Q we also find an interview with the CTO, Clint Landrock, who unveils numerous case studies related to their nano-manufacturing commercialization efforts.
First and foremost, MMAT has been granted a parent-patent that includes it’s claim for nano-hole structures and applications for those features in the security and authentication industry. It also includes claims for the use of those nano-scale structures that are smaller than a wavelength of light in conjunction with printable electronic components, which would include electronic displays, batteries and solar cells.
Landrock states,”It seems like it could be used for a range of possible markets, including games and interactive displays for consumer products”. He even touches on how these displays could be used for specific light wave optical guides used in medical programs for sensing bacteria and disease or for drug application.
If we delve deeper, the initial purpose of this technology was to enhance solar panels by maximizing electron production, leading to more efficient and durable batteries. Considering their nano-scale structures are tinier than a wavelength of light, you can envision the implications for battery performance. Especially in the context of the ongoing global shift towards Electric Vehicles (EVs), this presents a significant opportunity to integrate such a groundbreaking technology.
However, given the immense demand for this technology across various applications, achieving scalability is critical, necessitating a roll-to-roll manufacturing approach to handle the high volume needed. Typically, scaling up can pose a significant hurdle, but what amplifies the excitement here is Landrock’s affirmation that they have effectively demonstrated, in collaboration with a third party, the ability to produce and operate their technology using high-speed roll-to-roll casting machines. The outcomes were remarkably positive with 100% through-put yield. Which means 100% of the images produced could be used for commercial purposes.
Another common barrier to entry is the costs associated with scaling a new technology. To make things even better, their technology also aligns with global initiative to be more green. Landrock states, “Also, this is a true green technology that will not harm the environment, costs less to produce than the current technology and provides far improved security for authentication requirements”.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Agreement with Panasonic:
On September 29th, 2023 MMAT teamed up with Panasonic Industry Co. (An operating company in charge of device business within the Panasonic Group) to advance transparent conductive materials. This collaboration aims to enhance the supply of NANOWEB® films, which would benefit sectors like automotive and consumer electronics, transparent film antennas, heaters, and electromagnetic shielding.
The demand for ultra-low sheet resistance and high optical performance is increasing, particularly for flexible solar cells and smart windows. According to BCC Research, the global transparent conductive films market is projected to reach $7.6 billion by 2025 from $4.9 billion in 2020, growing at a CAGR of 9.2%.
George Palikaras, CEO of META, highlighted the importance of this collaboration, emphasizing their shared goal to advance transparent conductive materials. Panasonic Industry has a track record of mass-producing quality transparent conductive films, making them a strategic partner for META.
Yuichi Yoshikawa, Director of Touch Solutions Business Unit at Panasonic Industry, expressed excitement about the collaboration, foreseeing it providing advanced solutions and creating new possibilities across various applications.
This collaboration merges NANOWEB® metal mesh designs by META with Panasonic Industry’s cutting-edge process technology, aiming to set new industry standards. They will showcase their collaborative solutions at CEATEC 2023 which goes from Oct 17 – Oct 20 to demonstrate the potential applications of this partnership.
This agreement holds significant weight. Keep a vigilant watch, the event is around the corner and they’re expecting ~200,000 attendees. A collaboration with a well-established and reputable name like Panasonic certainly changes the landscape, and could bring notable shifts for the company in the near future.
Conclusion:
In essence, MMAT stands at a pivotal moment. With the resolution of lawsuits, it appears things could be looking up. Coupled with their recent strategic maneuvers and advancements in commercialization, MMAT certainly holds promise. Could they potentially see a significant valuation upswing in the near term? The consensus among thousands online is yes. Considering the innovation and potential impact, MMAT is undeniably a company worth vigilant monitoring in the months ahead.
We will update you on MMAT when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Shares of Clean Vision Corporation (OTC: CLNV) have seen an uptrend of 180% since September 18th, 2023. This emerging developer of sustainable clean technology hasn’t had a press release since September 7th, 2023. The company’s seen substantial growth without targeted press releases to update investors. However if you look closer, a deeper narrative emerges. We found a number of SEC filings and there also appears to be a number of notable Twitter users talking about the company, believing it has substantial prospects near term. Before we move forward, let’s pause to gain a deeper understanding of the landscape surrounding Clean Vision.
Background:
Clean Vision is led by Dan Bates, and their goal is to tackle the global plastic waste crisis head-on. Their wholly owned subsidiary, Clean Seas, has developed the Plastic Conversion Network (PCN), a groundbreaking technology aimed at diverting millions of tons of waste plastic from landfills, incineration, and oceans. The PCN converts this plastic feedstock into clean fuels and green hydrogen, significantly reducing reliance on fossil fuels and lowering the carbon footprint.
For a 2 minute overview on the company, we found a great video that CLNV’s subsidiary put together just recently. Feel free to follow this link to watch.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Clean Seas utilizes proven pyrolysis technology to produce environmentally friendly products, which are sold to multinational petrochemical companies, driving the circular plastic economy. Operational PCN facilities are already in place in Morocco and India, with additional conversion facilities in development across West Virginia, Arizona, and Southeast Asia. Long-term feedstock supply agreements exceeding one million tons of waste plastic annually have been secured at no cost.
Furthermore, the company aligns with ESG investment criteria and adheres to five United Nations Sustainable Development Goals (SDGs). Backed by a seasoned management team with extensive experience in sustainability, international development, and finance, Clean Vision is poised to be a key player in the clean energy economy. They invite collaboration to make a significant impact on the global waste plastic problem, striving for a cleaner environment for future generations.
No Press Releases:
Often with OTC companies, it’s common that updates within the company aren’t always accompanied by press releases. If you can’t find press releases, it’s a good practice to search for SEC filings to ensure you haven’t overlooked any important information. There are a number of SEC filings to keep in mind that can be found on CLNV’s IR portal of their website. If you can’t find information on a public issuers website, you can also find anything you need here.
S-1 Filing:
There were a number of filings from August 31, 2023 to October 3rd, 2023 which were mainly related to their S-1 filing. This means the company will likely be up-listing to the NASDAQ. For those that don’t know what this filing is, here’s a brief description:
The S-1 registration statement is a comprehensive document that includes detailed information about the company, its business operations, financials, risks, management team, and the proposed terms of the public offering. It’s a crucial step in the process of conducting an initial public offering (IPO) and making shares available for public trading on major exchanges such as NASDAQ or the New York Stock Exchange (NYSE).
A S-1 registration document is often lengthy and complex, making it challenging for everyday retail investors to grasp. To assist in understanding, we’ve broken down and simplified the initial page of CLNV’s S-1 for you:
CLNV S-1 Filing:
In essence their filing is saying that they are selling a large number of company shares (820,598,246 shares) owned by different people. These shares are part of Clean Vision Corporation, a company based in Nevada.
The people who own these shares can sell them at different times based on certain agreements they had with the company. The agreements are related to three specific dates and are linked to previous investments made by these shareholders.
May Purchase Agreement: This allows the sale of up to 269,042,604 shares based on an investment deal made on May 26, 2023.
February Purchase Agreement: This allows the sale of up to 454,166,752 shares based on an investment deal made on February 17, 2023.
August Purchase Agreement: This allows the sale of up to 97,388,890 shares based on an investment deal made on July 31, 2023.
The company, Clean Vision Corporation, won’t directly make money from the sale of these shares. But if the people who buy these shares decide to use certain options to get more shares, then the company will receive some money. The people selling these shares will handle the costs associated with selling them, like commissions and discounts. The company will handle the paperwork costs associated with registering these shares for sale.
8-K Filing:
It’s also important to note that the company filed an 8-K on October 3rd, 2023 mentioning that on September 26, 2023, Clean Vision Corporation made a deal with an investor. The investor agreed to buy 10,000,000 shares of the company’s common stock for a total of $198,000. The agreement was signed on that day but didn’t take effect until the investor paid the money on September 28, 2023.
As per this deal, the company sold these 10,000,000 shares to the investor at a price of $0.0198 per share. Additionally, the investor received 5,000,000 more shares, but these have restrictions on their sale. The company also has to register these 10,000,000 shares with the U.S. Securities and Exchange Commission within 45 days from the signing date, allowing the investor to sell them in the future.
Twitter Posts:
While exploring online discussions, we found Twitter users @FrankieBstock, @realsheepwolf, and @borders_LLC all showing enthusiasm for Clean Vision’s future potential. Although it’s important to remember that their views aren’t financial advice, it’s encouraging to see how CLNV’s journey has progressed since their initial thoughts on the company.
@realsheepwolf put things into perspective in a simple, comprehensive format for investors to see key takeaways.
“HUGE THINGS HAPPENINGS
✨non-dilutive financing
✨massive revenue growth
✨Morocco India operational
✨WV operational Q-1 2024
✨Arizona operational Q2-Q3 2024
✨Michigan, Mass., Puerto Rico moving toward definitive agreements.
✨Uplisting to NASDAQ”
Following the mentioned individuals, the video showcasing the company’s story above has been widely shared by @FrankieBstock and @borders_LLC.
As the company experiences a surge in daily trading activity another larger user jumped in on the action and took note of the company – expressing surprise at the remarkable increase in trading volume. Specifically, on October 4th, 2023, CLNV achieved a trading volume that equaled nearly $450,000 worth. This is quite significant, especially considering a singular share is being traded for a mere $0.05.
Conclusion:
Clean Vision’s story has garnered significant attention of late, suggesting the possibility of broader recognition among retail traders. It may only be a matter of time before various investment communities direct their focus towards the company. Notably, certain influential users on Twitter, some with a substantial following nearing 20,000 people, are actively discussing the company, adding to its visibility.
However it’s important to note that consistent with their nature, these stocks demonstrate high volatility, carrying the inherent risk of potential loss of your entire investment. Yet, for some, the allure lies in the thrill of potentially substantial returns, akin to the potential behind the roll of dice at a casino.
We will update you on CLNV when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by onehundredseventyfive from Pixabay
Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis
Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments
Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024
Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?
1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead
-
Uncategorized2 years agoMeta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)
-
Micro Cap Insider3 years ago
Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)
-
Media & Technology4 years agoHealthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward
-
Media & Technology4 years ago
AMECA Mining RM; the Rise of Southcorp Capital, Inc. (OTCMKTS: STHC)
-
Media & Technology4 years agoSNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.
-
BioPharma3 years agoAsia Broadband (OTCMKTS: AABB) On the Move Northbound Since Sub $0.08 Dip as Crypto Innovator Elevates AABB Crypto Exchange & Enters the NFT Space
-
Uncategorized2 years agoMeta Materials Inc (OTCMKTS: MMTLP) Short Squeeze S-1a4 Filing Signals S1 Approval Could Be Days Away (Next Bridge Hydrocarbons Spin-Off)
-
BioPharma3 years agoHumbl Inc (OTCMKTS: HMBL) Major Reversal as Powerful Advisor Rejoins the Team & Looks to Uplist to Major Exchange
Lyla Armstrong
April 28, 2021 at 9:52 pm
$HCMC StockTwits Team: https://stocktwits.com/Lyla_armstrong
Lyla_armstrong – HUGEE HCMC TEAM – All HCMC News and Free Filings! #Join!
mike
April 29, 2021 at 11:22 am
once this lawsuit settles in HCMC’s favour(another much larger company is suing the same company for similar charges) HCMC will quickly reach its 52 week high and beyond.I’ve owned shares since it traded at .0010!
Keep watching the news for developments.This will be a wild ride!
Load up while you can at these cheap prices….I bought more.
mike
April 29, 2021 at 11:29 am
Once HCMC wins this lawsut(a much larger company suing same defendant for similar infringements….BOTH companies can’t be wrong!!!),it will be a wild ride as pent-up demand pushes it quickly past its 52 week high.;notice the daily share volume of this stock!
mike
April 29, 2021 at 11:33 am
Have to pay attention to a stock that had a 2 billion share volume yesterday like RNVA had.
norman
May 1, 2021 at 1:57 am
I’m holding 3 million shares and going for 4 million. HCMC will be my legacy for my grandchildren and their children. I’ll break $1 million at .35/share.